95 related articles for article (PubMed ID: 3808571)
1. Chemotherapeutic effects of 13 nitrosoureas on the LSA lymphoma ascites tumor of the C57BL mouse.
Feola JM; Maruyama Y
Oncology; 1986; 43(6):378-84. PubMed ID: 3808571
[TBL] [Abstract][Full Text] [Related]
2. Cure rates and tumor resistance in cured mice after nitrosourea treatment of EMT6 ascites tumors.
Feola JM; Maruyama Y
Oncology; 1986; 43(6):372-7. PubMed ID: 2949185
[TBL] [Abstract][Full Text] [Related]
3. Host resistance to tumor after cure of advanced LSA lymphoma by treatment with BCNU and chlorozotocin.
Feola J; Maruyama Y
Cancer Treat Rep; 1979 Aug; 63(8):1409-12. PubMed ID: 157809
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulation by various nitrosoureas and its effect on the survival of the murine host bearing a syngeneic tumor.
Nagarkatti M; Toney DM; Nagarkatti PS
Cancer Res; 1989 Dec; 49(23):6587-92. PubMed ID: 2573418
[TBL] [Abstract][Full Text] [Related]
5. [Comparative effect of administration schedules on the antitumor activities of 3 water-soluble nitrosoureas, ACNU, GANU and MCNU against L1210 leukemia].
Kato T; Ota K
Gan To Kagaku Ryoho; 1983 May; 10(5):1354-62. PubMed ID: 6223585
[TBL] [Abstract][Full Text] [Related]
6. Examination of newly synthesized 2-chloroethyl-nitrosoureas on rat leukemia L 5222.
Zeller WJ; Eisenbrand G
Oncology; 1981; 38(1):39-42. PubMed ID: 7443175
[TBL] [Abstract][Full Text] [Related]
7. Examination of four newly synthesized 2-chloroethylnitrosoureas in comparison with BCNU, CCNU, MeCCNU, chlorozotocin and hydroxyethyl-CNU in preterminal rat leukemia L 5222.
Zeller WJ; Eisenbrand G; Fiebig HH
J Cancer Res Clin Oncol; 1979 Sep; 95(1):43-9. PubMed ID: 159309
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effects of GANU and other nitrosourea derivatives against transplantable leukemias and solid tumors in mice.
Sava G; Giraldi T
Cancer Chemother Pharmacol; 1983; 10(3):167-9. PubMed ID: 6222844
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory effects of nitrosoureas on the phenotype and functions of T cells in the thymus and periphery.
Clary S; Nagarkatti PS; Nagarkatti M
Immunopharmacology; 1990; 20(3):153-64. PubMed ID: 2149719
[TBL] [Abstract][Full Text] [Related]
10. Nitrosoureas: a review of experimental antitumor activity.
Schabel FM
Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of new nitrosoureas on Yoshida sarcoma ascites cells implanted into the colon wall of rats.
Habs M; Reinbold H; Eisenbrand G; Bhide S; Goga-Ionescu S; Schmähl D
J Cancer Res Clin Oncol; 1981; 101(3):285-302. PubMed ID: 7309781
[TBL] [Abstract][Full Text] [Related]
12. Biological and biochemical properties of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea (NSC D 254157), a nitrosourea with reduced bone marrow toxicity.
Fox PA; Panasci LC; Schein PS
Cancer Res; 1977 Mar; 37(3):783-7. PubMed ID: 138478
[TBL] [Abstract][Full Text] [Related]
13. In vitro cytotoxicity and differential cellular sensitivity of derivatives of diamino acids. II. N1-methyl, N1-allyl, N1-(2-chloroethyl) and N1-propargyl nitrosoureas.
Dulude H; Salvador R; Gallant G
Anticancer Res; 1995; 15(3):853-8. PubMed ID: 7645970
[TBL] [Abstract][Full Text] [Related]
14. Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo.
Stephens TC; Adams K; Peacock JH
Br J Cancer; 1986 Feb; 53(2):237-45. PubMed ID: 3954945
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
Fujimoto S; Tashiro T; Ogawa M
Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
[TBL] [Abstract][Full Text] [Related]
16. Evidence for host resistance in 1,3 bis(2-chloroethyl)-1-nitrosourea treatment induced in syngeneic LSA lymphoma.
Maruyama Y; Williams A; Feola JM; Nava C
J Cancer Res Clin Oncol; 1982; 103(2):107-18. PubMed ID: 7096433
[TBL] [Abstract][Full Text] [Related]
17. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
Mulcahy RT; Siemann DW
Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
[TBL] [Abstract][Full Text] [Related]
18. 1,3-bis(2-chloroethyl)-1-nitrosourea treatment of spontaneous radiogenic C57BL mouse leukemia/lymphoma.
Maruyama Y; Feola JM; Muir W
Gan; 1983 Jun; 74(3):426-36. PubMed ID: 6309602
[TBL] [Abstract][Full Text] [Related]
19. Clinical comparison of the nitrosoureas.
Wasserman TH; Slavik M; Carter SK
Cancer; 1975 Oct; 36(4):1258-68. PubMed ID: 1100221
[TBL] [Abstract][Full Text] [Related]
20. Comparison of antitumor activities of nitrosourea derivatives against mammary breast carcinoma (MX-1) in nude mice.
Inoue K; Fujimoto S; Ogawa M
Gan; 1980 Oct; 71(5):686-91. PubMed ID: 7227717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
